CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company dedicated to destroying cancer differently
CytomX Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company dedicated to destroying cancer differently. CytomX is advancing potential first-in-class and best-in-class antibody-based therapeutics created using its Probody® technology platform that could meaningfully improve outcomes for cancer patients.